TRACK THE VAX

By: MedPage Today
Listen for free

  • Summary

  • It was a global race that led to the largest mass vaccination campaign in American history. What comes after a COVID-19 vaccine? Track the Vax, a weekly podcast from MedPage Today, returns for Season 2 to continue to examine the "New Normal" brought about through the global vaccination effort, continued vaccine development, research and impact from the vaccine rollout. Hosted and produced by medical correspondent Serena Marshall, with Executive producer health journalist Lara Salahi this podcast is devoted to the science and a data driven look at what comes next.
    Show more Show less
Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Coming Soon: Track the Vax

    Coming Soon: Track the Vax
    Nov 25 2020
    Following the race to the COVID-19 Vaccine. Track the Vax will be a limited-series podcast with a goal of explaining how the COVID vaccines work, understanding the mechanism behind their effectiveness, talking to those behind the safety goggles...and trying to stay out of the political fray…and get back to the science. However, like all things these days, when it comes to FDA approval, we may have to step into the political ring. As the government possibly prepares to fast-track a vaccine before phase 3 trials end and a recent vaccine trial was "paused" due to political pressure, we will offer either episodes or perhaps supplemental shows to dive into those issues (in addition to the weekly drop).
    Show more Show less
    1 min
  • FDA Chief Vows Transparency in Vaccine Approvals

    FDA Chief Vows Transparency in Vaccine Approvals
    Dec 1 2020
    As pharmaceutical companies move at warp speed to develop a vaccine, the U.S. agency at the center of emergency approvals is "working around the clock" to evaluate whether the limited data meets the standard for emergency approval, FDA commissioner Dr. Stephen Hahn tells our weekly podcast Track the Vax. So far, U.S.- based Moderna as well as Pfizer and BioNTech have both submitted requests for emergency FDA authorization for their respective vaccines. "We're looking at the data right now and it's too early to draw any conclusions but I can assure you our team is working night and day on this," Hahn said. "When the data analysis is ready... we'll make that available to the american people and the committee." The first immunisations using the BioNTech and Pfizer vaccine could take place in the U.K as early as this week. The FDA's Vaccines and Related Biological Products Advisory Committee is scheduled to discuss the request for emergency use authorization on December 10. Hahn told us he won't prejudge what their decision will be, but says their job is to weigh a variety of criteria as it reviews the data, including the participants included in the studies.
    Show more Show less
    21 mins
  • How Do the New COVID-19 Vaccines Work?

    How Do the New COVID-19 Vaccines Work?
    Dec 9 2020
    The two vaccines showing most promise - and moving first through the regulatory process - are a new type of vaccine known as messenger RNA vaccines. Before COVID-19, mRNA vaccines have never been on the market, but they have been studied. To learn more about the mRNA vaccine technology we chatted with Richard Kuhn, Ph D, who holds an endowed chair at Purdue University and serves as editor-in-chief of Virology.
    Show more Show less
    27 mins

What listeners say about TRACK THE VAX

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available